← All diseases
Brain and nervous system
Parkinson's disease
Would you like to receive a message when there is new research about Parkinson's Disease? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as new research on Parkinson's Disease is published. View what Premium costs.
Publications and studies (3464)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A comprehensive review on Jiao-tai-wan: Traditional application, pharmacokinetics, and therapeutic mechanisms in multiple disorders. (2026/12/06) ♡
- Nasal microenvironment self-responsive herbal hydrogel alleviates Parkinsonian pathology via the inhibition of α-synuclein liquid-liquid phase separation. (2026/12/01) ♡
- Generalized osteoporosis but not axial osteopenia is associated with cognitive impairment in Parkinson's disease. (2026/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The footprint of ethnopharmacology in drug discovery (ISE-APSS2024). (2026/11/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chinese herbal and natural compounds for Parkinson's disease: Myth or truth. (2026/11/15) ♡
- Mitochondria-associated endoplasmic reticulum membranes and calcium ion exchange: A novel direction for aging and neurodegenerative diseases. (2026/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Natural monomer compounds in neurodegenerative diseases: Targeting ferroptosis and neuroinflammation. (2026/09/13) ♡
- Reproducible social phenotyping of 5xFAD mice in the Agora maze (Sociobox). (2026/09/13) ♡
- Targeting the NLRP3-NEK7 axis with rebamipide: Drug repurposing in Parkinson's disease. (2026/09/01) ♡
- When copper turns killer: Decoding copper dyshomeostasis and cuproptosis in neurodegenerative pathogenesis and precision metal interventions. (2026/09/01) ♡
- Deep learning-based cognitive impairment brain imaging analysis: New methods, new technologies, and new paradigms. (2026/09/01) ♡
- Wuzi Yanzong Pill improves Parkinson's disease via miR-146a-5p/USP3/NF-κB axis. (2026/09/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Benefits of 12-week self-paced training combined with melatonin supplementation on oxidative stress, inflammation, hyperlipidemia, and body composition in multiple sclerosis patients: A randomized controlled trial. (2026/09/01) ♡
- An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Stable Isotope-Resolved Metabolomics in Elucidating Mitochondrial Metabolic Reprogramming and Therapeutic Targets. (2026/09/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The adjunct use of Bifidobacterium animalis subsp. lactis BAMA-B06/BAu-B0111 improves the therapeutic efficacy of Liuwei'anxiao Capsule in alleviating constipation in Parkinson's Disease: A randomized controlled study. (2026/08/10) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Early-Onset Parkinson's Disease with 22q11.2 Microdeletion and Pathogenic GBA1 Variant. (2026/08/10) ♡
- Spatial-Spectral Fusion Enables Drug Repositioning by Capturing Indirect and Long-Range Associations in Biological Networks. (2026/08/10) ♡
- Seroprevalence Study of Toxoplasma gondii Infection in Psychiatric and Neurological Disorders. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities. (2026/08/10) ♡
- Factors associated with selection of total hip arthroplasty versus hemiarthroplasty for femoral neck fracture in older adults: a nationwide analysis of 99,084 cases. (2026/08/10) ♡
- 7 Tesla MRI with Quantitative Susceptibility Mapping: qualitative grading and quantitative focal measurements of the substantia nigra as a potential biomarker for Parkinson's disease. (2026/08/10) ♡
- Panax quinquefolius ginsenosides for neuroprotection in Parkinson's disease via TNF-α inhibition. (2026/08/10) ♡
- Factors associated with the dual-task cost of walking in people with Parkinson's disease. (2026/08/10) ♡
- Tardive blepharospasm. (2026/08/10) ♡
- Continuous theta burst stimulation delays L-DOPA-induced dyskinesia progression and ameliorates orolingual dyskinesia with concomitant reduction of striatal FosB/ΔFosB and neuroinflammation. (2026/08/09) ♡
- Peripheral GDF15 as an early biomarker for brain disorders: A large prospective cohort study. (2026/08/09) ♡
- Insulin like growth factor and cytokine signalling predict future cognitive impairment in Parkinson's disease. (2026/08/09) ♡
- Gait-cycle-locked cortico-subthalamic signatures underlying freezing of gait and their modulation in Parkinson's disease. (2026/08/09) ♡
- Early Longitudinal Brain Network Changes in Huntington's Disease Before Clinical Motor Onset. (2026/08/09) ♡
- Combined Transcranial Sonography of the Substantia Nigra and (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes. (2026/08/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Palatal Tremor of Progressive Ataxia with Palatal Tremor Can Disappear over Time: Pathophysiological Considerations. (2026/08/09) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. COVID-19 Amplifies Sex-Specific Dopamine and Glial Responses in a Parkinson's Disease Mouse Model. (2026/08/09) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Dual Anatomical Targeting or Dual-Target Stimulation in Tremor-Dominant Parkinson's Disease? (2026/08/09) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "Dual Anatomical Targeting or Dual-Target Stimulation in Tremor-Dominant Parkinson's Disease?". (2026/08/09) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "Alkaline phosphatases as a potential source of variability in foslevodopa response: Muscles beyond pharmacokinetics". (2026/08/09) ♡
- The Incidence of Sensorineural Hearing Loss Diagnoses in People with and without Parkinson's Disease. (2026/08/08) ♡
- Real-world gait changes preceding Parkinson's disease diagnosis in a population-scale UK biobank cohort. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Reprogramming-Driven Neuroimmunoregulation: Key Mechanisms and Therapeutic Opportunities and Challenges in Central Nervous System Disorders. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The gut-brain-mitophagy axis: Urolithin A as a transcriptional activator of Parkin in Alzheimer's and Parkinson's diseases. (2026/08/08) ♡
- Dopamine D2 receptor dependent and independent structural, intrinsic and synaptic adaptations in experimental parkinsonism. (2026/08/08) ♡
- Chemogenetic activation and inhibition of CaMKⅡα-positive neurons in the dorsal hippocampus modulate spatial working memory and hippocampus-dependent memory in the hemiparkinsonian rat. (2026/08/08) ♡
- Cannabidiol confers neuroprotection against 6-OHDA toxicity by rescuing Nrf2 proteostasis and preserving mitochondrial integrity. (2026/08/08) ♡
- Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial. (2026/08/07) ♡
- Intranasal Delivery of Gallium-Quercetin Nanoparticles for Multi-Target Ferroptosis Inhibition in Parkinson's Disease. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. GBA1 variants and mortality in Parkinson's disease: A systematic review and meta-analysis. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Quality management and specifications of multidisciplinary Parkinson's disease management: an expert opinion. (2026/08/07) ♡
- Mesenteroaxial gastric volvulus associated with a wandering spleen in an older woman treated with anterior gastropexy and splenectomy: a case report. (2026/08/07) ♡
- Effect of genetic factors on [(18)F]FDG PET metabolic phenotypes in dementia with Lewy bodies. (2026/08/07) ♡
- Reliability and convergent validity of the 6-minute pegboard and ring test in people with Parkinson's disease: a cross-sectional study. (2026/08/07) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.